American Century Companies
CHRS icon

American Century Companies’s Coherus Oncology CHRS Stock Holding History

American Century Companies’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43,242
Closed -$73.1K – 2902
2026
Q1 		$73.1K Buy
+43,242
New +$76.8K ﹤0.01% 2797
2022
Q2 		– Sell
-36,075
Closed -$463K – 2319
2022
Q1 		$463K Sell
36,075
-38,840
-52% -$494K ﹤0.01% 1996
2021
Q4 		$1.2M Sell
74,915
-76
-0.1% -$1.33K ﹤0.01% 1580
2021
Q3 		$1.21M Buy
74,991
+49,952
+199% +$732K ﹤0.01% 1520
2021
Q2 		$346K Sell
25,039
-40,100
-62% -$568K ﹤0.01% 1995
2021
Q1 		$952K Buy
65,139
+28,240
+77% +$479K ﹤0.01% 1453
2020
Q4 		$641K Buy
36,899
+22,442
+155% +$400K ﹤0.01% 1456
2020
Q3 		$265K Buy
+14,457
New +$269K ﹤0.01% 1595

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

American Century Companies's CHRS Position: Q2 2026 in Review

American Century Companies sold out of Coherus Oncology (CHRS) in Q2 2026, closing a stake of 43,242 shares — an estimated $73.1K sold.

American Century Companies first reported a position in CHRS in Q3 2020 and held it in 8 quarters. The position peaked at $1.21M in Q3 2021. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • American Century Companies reported no remaining Coherus Oncology position as of Q2 2026 after selling out during the quarter.
  • American Century Companies sold 43,242 Coherus Oncology shares in Q2 2026, an estimated $73.1K.
  • American Century Companies first reported a position in Coherus Oncology in Q3 2020 and held it in 8 quarters.
  • American Century Companies's Coherus Oncology position peaked at $1.21M in Q3 2021.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.